Cargando…
Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel
In June 2011 the Canadian National Advisory Committee on Blood and Blood Products sponsored an international consensus conference on transfusion and trauma. A panel of 10 experts and two external advisors reviewed the current medical literature and information presented at the conference by invited...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388668/ https://www.ncbi.nlm.nih.gov/pubmed/22188866 http://dx.doi.org/10.1186/cc10498 |
_version_ | 1782237222856032256 |
---|---|
author | Dzik, Walter H Blajchman, Morris A Fergusson, Dean Hameed, Morad Henry, Blair Kirkpatrick, Andrew W Korogyi, Teresa Logsetty, Sarvesh Skeate, Robert C Stanworth, Simon MacAdams, Charles Muirhead, Brian |
author_facet | Dzik, Walter H Blajchman, Morris A Fergusson, Dean Hameed, Morad Henry, Blair Kirkpatrick, Andrew W Korogyi, Teresa Logsetty, Sarvesh Skeate, Robert C Stanworth, Simon MacAdams, Charles Muirhead, Brian |
author_sort | Dzik, Walter H |
collection | PubMed |
description | In June 2011 the Canadian National Advisory Committee on Blood and Blood Products sponsored an international consensus conference on transfusion and trauma. A panel of 10 experts and two external advisors reviewed the current medical literature and information presented at the conference by invited international speakers and attendees. The Consensus Panel addressed six specific questions on the topic of blood transfusion in trauma. The questions focused on: ratio-based blood resuscitation in trauma patients; the impact of survivorship bias in current research conclusions; the value of nonplasma coagulation products; the role of protocols for delivery of urgent transfusion; the merits of traditional laboratory monitoring compared with measures of clot viscoelasticity; and opportunities for future research. Key findings include a lack of evidence to support the use of 1:1:1 blood component ratios as the standard of care, the importance of early use of tranexamic acid, the expected value of an organized response plan, and the recommendation for an integrated approach that includes antifibrinolytics, rapid release of red blood cells, and a foundation ratio of blood components adjusted by results from either traditional coagulation tests or clot viscoelasticity or both. The present report is intended to provide guidance to practitioners, hospitals, and policy-makers. |
format | Online Article Text |
id | pubmed-3388668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33886682012-12-08 Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel Dzik, Walter H Blajchman, Morris A Fergusson, Dean Hameed, Morad Henry, Blair Kirkpatrick, Andrew W Korogyi, Teresa Logsetty, Sarvesh Skeate, Robert C Stanworth, Simon MacAdams, Charles Muirhead, Brian Crit Care Review In June 2011 the Canadian National Advisory Committee on Blood and Blood Products sponsored an international consensus conference on transfusion and trauma. A panel of 10 experts and two external advisors reviewed the current medical literature and information presented at the conference by invited international speakers and attendees. The Consensus Panel addressed six specific questions on the topic of blood transfusion in trauma. The questions focused on: ratio-based blood resuscitation in trauma patients; the impact of survivorship bias in current research conclusions; the value of nonplasma coagulation products; the role of protocols for delivery of urgent transfusion; the merits of traditional laboratory monitoring compared with measures of clot viscoelasticity; and opportunities for future research. Key findings include a lack of evidence to support the use of 1:1:1 blood component ratios as the standard of care, the importance of early use of tranexamic acid, the expected value of an organized response plan, and the recommendation for an integrated approach that includes antifibrinolytics, rapid release of red blood cells, and a foundation ratio of blood components adjusted by results from either traditional coagulation tests or clot viscoelasticity or both. The present report is intended to provide guidance to practitioners, hospitals, and policy-makers. BioMed Central 2011 2011-12-08 /pmc/articles/PMC3388668/ /pubmed/22188866 http://dx.doi.org/10.1186/cc10498 Text en Copyright ©2011 BioMed Central Ltd |
spellingShingle | Review Dzik, Walter H Blajchman, Morris A Fergusson, Dean Hameed, Morad Henry, Blair Kirkpatrick, Andrew W Korogyi, Teresa Logsetty, Sarvesh Skeate, Robert C Stanworth, Simon MacAdams, Charles Muirhead, Brian Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel |
title | Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel |
title_full | Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel |
title_fullStr | Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel |
title_full_unstemmed | Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel |
title_short | Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel |
title_sort | clinical review: canadian national advisory committee on blood and blood products - massive transfusion consensus conference 2011: report of the panel |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388668/ https://www.ncbi.nlm.nih.gov/pubmed/22188866 http://dx.doi.org/10.1186/cc10498 |
work_keys_str_mv | AT dzikwalterh clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT blajchmanmorrisa clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT fergussondean clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT hameedmorad clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT henryblair clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT kirkpatrickandreww clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT korogyiteresa clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT logsettysarvesh clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT skeaterobertc clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT stanworthsimon clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT macadamscharles clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel AT muirheadbrian clinicalreviewcanadiannationaladvisorycommitteeonbloodandbloodproductsmassivetransfusionconsensusconference2011reportofthepanel |